2005
DOI: 10.1016/j.tox.2004.07.009
|View full text |Cite
|
Sign up to set email alerts
|

In vitro inhibitory effect of aflatoxin B1 on acetylcholinesterase activity in mouse brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
22
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(23 citation statements)
references
References 39 publications
(53 reference statements)
1
22
0
Order By: Relevance
“…The first work that has reported the ability to inhibit AChE enzyme was published on Toxicology by Cometa et al [203]. In this work the inhibition of AChE extracted from mouse brain by AFB 1 , was studied obtaining IC 50 equal 10 ppm.…”
Section: Effect Of Enzyme Sources Incubation Time and Enzyme Loadingmentioning
confidence: 98%
“…The first work that has reported the ability to inhibit AChE enzyme was published on Toxicology by Cometa et al [203]. In this work the inhibition of AChE extracted from mouse brain by AFB 1 , was studied obtaining IC 50 equal 10 ppm.…”
Section: Effect Of Enzyme Sources Incubation Time and Enzyme Loadingmentioning
confidence: 98%
“…In the case of the aflatoxins, this approach pointed to either an enzyme that metabolizes AFB 1 into a detectable compound or an enzyme that can be inhibited by AFB 1 . The inhibition by AFB 1 of acetylcholinesterase (AChE), a key enzyme in the transmission of nerve impulses has been investigated (Cometa et al, 2005). The AFB 1 inhibition towards AChE extracted from mouse brain was studied and the implications in terms of kinetic mechanism and toxicity discussed.…”
Section: Introductionmentioning
confidence: 99%
“…Animal studies demonstrated that the ventral mesencephalon, hippocampus, striatum, and cerebellum are the main OTA targets in the brain of adult rats exposed to OTA, excluding the rest of the brain (Belmadani et al 1998). Other proposed mechanisms are: AFB1 non-competitively inhibits mouse brain AChE by blocking access of the substrate to the active site or by inducing a defective conformational change in the enzyme through non-covalent binding interacting with the AChE peripheral binding site (Cometa et al 2005).…”
Section: Discussionmentioning
confidence: 99%